Your browser doesn't support javascript.
loading
A randomized, double-blind, phase II study of oral histone deacetylase inhibitor resminostat plus S-1 versus placebo plus S-1 in biliary tract cancers previously treated with gemcitabine plus platinum-based chemotherapy.
Ueno, Makoto; Morizane, Chigusa; Furukawa, Masayuki; Sakai, Daisuke; Komatsu, Yoshito; Nakai, Yousuke; Tsuda, Masahiro; Ozaka, Masato; Mizuno, Nobumasa; Muto, Manabu; Fukutomi, Akira; Ikeda, Masafumi; Tsuji, Akihito; Katanuma, Akio; Moriwaki, Toshikazu; Kajiwara, Takeshi; Ishii, Hiroshi; Negoro, Yuji; Shimizu, Satoshi; Nemoto, Noriko; Kobayashi, Shingo; Makino, Keigo; Furuse, Junji.
Afiliación
  • Ueno M; Department of Gastroenterology, Hepatobiliary and Pancreatic Medical Oncology Division, Kanagawa Cancer Center, Kanagawa, Japan.
  • Morizane C; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Furukawa M; Department of Hepato-Biliary-Pancreatology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Sakai D; Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Komatsu Y; Division of Cancer Center, Hokkaido University Hospital, Hokkaido, Japan.
  • Nakai Y; Department of Gastroenterology, Department of Endoscopy and Endoscopic Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Tsuda M; Department of Gastroenterological Oncology, Hyogo Cancer Center, Hyogo, Japan.
  • Ozaka M; Hepato-Biliary-Pancreatic Medicine Department, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Mizuno N; Department of Gastroenterology, Aichi Cancer Center Hospital, Aichi, Japan.
  • Muto M; Department of Clinical Oncology, Kyoto University Hospital, Kyoto, Japan.
  • Fukutomi A; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Ikeda M; Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Tsuji A; Department of Clinical Oncology, Faculty of medicine, Kagawa University, Kagawa, Japan.
  • Katanuma A; Center for Gastroenterology, Teine-keijinkai hospital, Hokkaido, Japan.
  • Moriwaki T; Department of Gastroenterology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
  • Kajiwara T; Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Ehime, Japan.
  • Ishii H; Clinical Research Center, Chiba Cancer Center, Chiba, Japan.
  • Negoro Y; Division of Clinical Oncology, Kochi Health Sciences Center, Kochi, Japan.
  • Shimizu S; Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan.
  • Nemoto N; Pharmaceutical Research & Development Department, Yakult Honsha Co., Ltd., Tokyo, Japan.
  • Kobayashi S; Pharmaceutical Research & Development Department, Yakult Honsha Co., Ltd., Tokyo, Japan.
  • Makino K; Pharmaceutical Research & Development Department, Yakult Honsha Co., Ltd., Tokyo, Japan.
  • Furuse J; Department of Medical Oncology, Faculty of Medicine, Kyorin University, Tokyo, Japan.
Cancer Med ; 10(6): 2088-2099, 2021 03.
Article en En | MEDLINE | ID: mdl-33635605
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ácido Oxónico / Sulfonamidas / Neoplasias del Sistema Biliar / Protocolos de Quimioterapia Combinada Antineoplásica / Tegafur / Ácidos Hidroxámicos Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Cancer Med Año: 2021 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ácido Oxónico / Sulfonamidas / Neoplasias del Sistema Biliar / Protocolos de Quimioterapia Combinada Antineoplásica / Tegafur / Ácidos Hidroxámicos Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Cancer Med Año: 2021 Tipo del documento: Article País de afiliación: Japón